| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102162A2 Novel tolerogenic dendritic cells and therapeutic uses therefor |
| 12/11/2003 | WO2003102157A2 Synthetic antibody phage libraries |
| 12/11/2003 | WO2003102156A2 Heterologous stimulus-gated ion channels and methods of using same |
| 12/11/2003 | WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 12/11/2003 | WO2003102143A2 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102134A2 Pancreatic acinar cells into insulin producing cells |
| 12/11/2003 | WO2003102127A2 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | WO2003102126A1 A method of cell therapy using fused cell hybrids |
| 12/11/2003 | WO2003102125A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | WO2003102123A2 Culture systems for the sterile continuous cultivation of cells |
| 12/11/2003 | WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102021A2 Cotton rat lung cells for virus culture |
| 12/11/2003 | WO2003102016A2 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 12/11/2003 | WO2003101586A1 Cell recovery |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101473A1 Suicide tetramers comprising mhc class i and uses thereof |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101202A1 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003101189A1 Inducible eukaryotic expression system |
| 12/11/2003 | WO2003101187A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | WO2003080820A3 Mammalian permanent growth factor-independent cell line and method of its production |
| 12/11/2003 | WO2003078597A9 Tissue engineering |
| 12/11/2003 | WO2003078588A9 Primitive and proximal hepatic stem cells |
| 12/11/2003 | WO2003074685A3 Il-10 gene transfer to peripheral blood mononuclear cells |
| 12/11/2003 | WO2003074670A3 Lis promoter for expression of transgenes in floral tissues |
| 12/11/2003 | WO2003072707B1 Compositions comprising reproductive cell media and methods for using such compositions |
| 12/11/2003 | WO2003071861A3 Vanillin biosynthetic pathway enzyme from vanilla planifolia |
| 12/11/2003 | WO2003066110A8 Pathogen reduction solution for platelets containing an endogenous photosensitizer and a glycolysis inhibitor. |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003065977A3 Modified antigen-presenting cells |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003053857A9 Forming and modifying dielctrically-engineered microparticles |
| 12/11/2003 | WO2003052110A3 Nucleic acid nematicides |
| 12/11/2003 | WO2003052084A3 Cell constructs cultured in vitro, preparation and uses |
| 12/11/2003 | WO2003048348A3 Production of viruses, viral isolates and vaccines |
| 12/11/2003 | WO2003048306A3 Polycistronic expression of antibodies |
| 12/11/2003 | WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
| 12/11/2003 | WO2003040324A3 Methods for mutating genes in cells and animals using insertional mutagenesis |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003035104A3 Compositions and methods for selected tumor treatment |
| 12/11/2003 | WO2003029458A3 Method for producing protein libraries and for selecting proteins from said libraries |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003026580A3 Interactive therapeutic enclosures |
| 12/11/2003 | WO2003025220A3 Fusion proteins useful for detecting analytes |
| 12/11/2003 | WO2003025132A3 Dna polymerases and mutants thereof |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003020877A3 Staining and sorting genomes and chromosomes using sequence-specific polyamides |
| 12/11/2003 | WO2003009740A3 Methods for treating or preventing sclerotic disorders using cd2-binding agents |
| 12/11/2003 | WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 12/11/2003 | WO2003001882A3 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000179A3 Chemically-modified progenipoietin conjugates |
| 12/11/2003 | WO2002099383A8 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 12/11/2003 | WO2002097085A3 Callus specific plant promoters |
| 12/11/2003 | WO2002089567A3 Sca2 knockout animal and methods of use |
| 12/11/2003 | WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002060928A3 Medane genes and proteins |
| 12/11/2003 | WO2002058588A3 Processes for making cryopreserved composite living constructs and products resulting therefrom |
| 12/11/2003 | WO2002050251A3 A device and method for seed-train expansion of mammalian cells |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2000070054A9 Pathogen-resistant grape plants |
| 12/11/2003 | US20030229925 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 12/11/2003 | US20030229923 Nucleic acid molecules encoding alternansucrase |
| 12/11/2003 | US20030229911 Compositions and methods for wound healing |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers |
| 12/11/2003 | US20030229046 Genetic engineering; polynucleotides; translation of codon of human cytomegalo virus |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229035 Method of restoring ciliated cell motility |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229008 Regenerating organs; anticancer agents; autoimmune disease; stabilization cells |
| 12/11/2003 | US20030228696 Novel insect cell line |
| 12/11/2003 | US20030228694 Transfection method and uses related thereto |
| 12/11/2003 | US20030228693 Multicompartment apparatus comprising porous membrane and alginic acid gel layer for propagation of tissues |
| 12/11/2003 | US20030228692 Tissue decellularization |
| 12/11/2003 | US20030228687 Separation and recovery of osteoblast progenitor cells for diagnosing, preventing and treating neurofibromentosis, osteoporosis and bone disorders |
| 12/11/2003 | US20030228686 Three dimensional vaginal tissue model containing immune cells |